Skip to main content

GLAXO

GlaxoSmithKline Pakistan Limited (PSX: GLAXO) has seen its profits fall for the first time in at least the last six years. The company's profits have grown continuously except 2016 when profits after tax remained flat as GSK Consumer Healthcare (PSX: GSKCH) demerged from Glaxo (GSK Pakistan). GSKCH demerged from GLAXO in 2015 and started operations as an independent company in 2016 and got listed on PSX in 2017. Glaxo manufactures and markets a wide variety of prescription medicines and vaccines, whereas GSKCH sells over-the-counter medicines and consumer products. The pharmaceutical giant booked a healthy topline growth of 8 percent year-on-year in 2019 versus the average sales growth of 6.5 percent in the last six years. Growth in topline is likely to have come its trade business that include antibiotics, analgesics, dermatology and respiratory segments. The commercial trade is a key driver of growth at GSK that fulfils the prescription demand generated by commercial activities. Also most likely included in the revenues are the sales of OTC products to GSKCH being manufactured by the GLAXO due to pending transfer of marketing authorisations by Drug Regulatory Authority of Pakistan. These amounted to Rs4.1 billion in 2018. Despite the growth in topline, the company's gross margins slipped due to higher costs of sales largely emanating from the currency devaluation and increase in price of raw material. In 2018 Annual Report, the company had highlighted that a challenge in 2019 will be the full year effect of the devaluation, compared to the half-year impact in 2018. However, contained expenses and growth in other income during the year provided some support to the bottomline, which declined by 7 percent year-on-year in 2019. Key risks for GLAXO in 2020 will continue to be foreign exchange volatility and high inflation risk impacting business profitability. DRAP issued a SRO last year to partially compensate the devaluation impact by allowing a one-time across the board price increase to the pharma companies y 15 percent, but Peshawar High Court issued a stay order halting the implementation increase in medicine prices.
Labels:

Comments

Post a Comment

Popular posts from this blog

State Bank of Pakistan issued new instructions over the Interest Rates and Deposit Rates

Post a Comment
Read more

Engro employees who were earlier in contact with the victim test negative for Covid-19

Engro Corporation Limited in its latest Press Release has informed that the employees who were in contact with their colleague affected by the COVID-19 ، undertook the lab test and tested negative for the virus. “On Tuesday (March 11), a few Engro employees who were in contact with their colleague affected by the Coronavirus COVID-19 – undertook the lab test. Results show that all of them have tested negative for the COVID-19 and they have been given a clear bill of health by doctors” the press release said. “The Engro employee who earlier tested positive for the virus is doing well at a local medical facility. The Engro team has been in close touch with the doctors and his family and is extending all possible support” it added. As communicated earlier, Engro offices at The Harbour Front Building shall resume on Monday, March 16, 2020. Employees will continue to work from home till then. In the interim, all Engro floors at the building will be deep cleaned and disinfected.  A...
Post a Comment
Read more

Govt to provide Rs 400m subsidy to farmers on PB Rope import

The government will provide 400 million rupees subsidy to framers on the import of PB Rope from the current cotton sowing season. According to Cotton Commissioner in the Ministry of National Food Security and Research Dr Khalid Abdullah، subsidy for PB Rope imports for about 2,00,000 hectares would be provided to help overcome threats of pest attacks on crop during its fruiting season and save the crop from damage. He said the amount is being allocated to enhance per-acre cotton output across the crop sowing areas of the country. Cotton Commissioner informed that government in close coordination with private sector had also designed a holistic program to ensure provision of certified cotton seed to farmers in order to achieve maximum per acre crop output during the season and get more profit.
Post a Comment
Read more